Menopause-related Hot Flashes Clinical Trial
Official title:
Yoga for Treatment of Hot Flashes and Menopausal Symptoms
Verified date | November 2023 |
Source | University of California, San Francisco |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The Yoga for Treatment of Hot Flashes and Menopausal Symptoms is an uncontrolled pilot clinical trial to determine the feasibility of recruitment and of evaluating yoga for the relief of menopausal hot flashes in 12 peri- or postmenopausal women. Participants will attend an Introductory Yoga Workshop, 8 yoga training sessions in 8 weeks, be assessed clinically before, during, and after training and contacted by telephone 3 months later.
Status | Completed |
Enrollment | 12 |
Est. completion date | December 2005 |
Est. primary completion date | |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 40 Years to 65 Years |
Eligibility | Inclusion Criteria: 1. Self-report =4 moderate to severe hot flashes per day or = 30 moderate to severe hot flashes per week. 2. Successful completion of a Hot Flash Diary. 3. Able and willing to attend yoga training sessions, maintain yoga logs, and practice yoga at home. Exclusion Criteria: 1. Inability to sign an informed consent or fill out questionnaires. 2. Use of other treatments for hot flashes (estrogens, progestins, clonidine, selective serotonin reuptake inhibitors,relaxation techniques or acupuncture) within 4 weeks of enrollment in the trial and do not agree to refrain from using these therapies for the duration of the trial. 3. Use of raloxifene or tamoxifen within three months of enrollment. 4. Any condition that, in the investigator's opinion, would preclude the participant from being able to understand and follow the yoga training or from completing the trial, including severe illness, plans to move, substance abuse, significant psychiatric problems, or dementia. - |
Country | Name | City | State |
---|---|---|---|
United States | UCSF Women's Health Clinical Research Center | San Francisco | California |
Lead Sponsor | Collaborator |
---|---|
University of California, San Francisco |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Reduction of number and severity of hot flashes will be summarized by the sample averages. |